| 1. |
|
|
| 2. |
- van Rheenen, W, et al.
(författare)
-
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
- 2021
-
Ingår i: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 53:12, s. 1636-
-
Tidskriftsartikel (refereegranskat)abstract
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry genome-wide association study (GWAS) including 29,612 patients with ALS and 122,656 controls, which identified 15 risk loci. When combined with 8,953 individuals with whole-genome sequencing (6,538 patients, 2,415 controls) and a large cortex-derived expression quantitative trait locus (eQTL) dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, short tandem repeats or regulatory effects. ALS-associated risk loci were shared with multiple traits within the neurodegenerative spectrum but with distinct enrichment patterns across brain regions and cell types. Of the environmental and lifestyle risk factors obtained from the literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. The combination of all ALS-associated signals reveals a role for perturbations in vesicle-mediated transport and autophagy and provides evidence for cell-autonomous disease initiation in glutamatergic neurons.
|
|
| 3. |
|
|
| 4. |
- Hu, Zhensong, et al.
(författare)
-
AMUSE-Antlia. I. Nuclear X-Ray Properties of Early-type Galaxies in a Dynamically Young Galaxy Cluster
- 2023
-
Ingår i: Astrophysical Journal. - 1538-4357 .- 0004-637X. ; 956:2
-
Tidskriftsartikel (refereegranskat)abstract
- To understand the formation and growth of supermassive black holes (SMBHs) and their coevolution with host galaxies, it is essential to know the impact of environment on the activity of active galactic nuclei (AGNs). We present new Chandra X-ray observations of nuclear emission from member galaxies in the Antlia cluster, the nearest non-cool core and the nearest merging galaxy cluster, residing at D = 35.2 Mpc. Its inner region, centered on two dominant galaxies NGC 3268 and NGC 3258, has been mapped with three deep Chandra ACIS-I pointings. Nuclear X-ray sources are detected in 7/84 (8.3%) early-type galaxies (ETG) and 2/8 (25%) late-type galaxies with a median detection limit of 8 × 1038 erg s−1. All nuclear X-ray sources but one have a corresponding radio continuum source detected by MeerKAT at the L band. Nuclear X-ray sources detected in early-type galaxies are considered the genuine X-ray counterpart of low-luminosity AGN. When restricted to a detection limit of log ( L X / erg s − 1 ) ≥ 38.9 and a stellar mass of 10 ≤ log ( M ⋆ / M ⊙ ) < 11.6 , six of 11 ETGs are found to contain an X-ray AGN in Antlia, exceeding the AGN occupation fraction of 7/39 (18.0%) and 2/12 (16.7%) in the more relaxed, cool core clusters, Virgo and Fornax, respectively, and rivaling that of the AMUSE-Field ETG of 27/49 (55.1%). Furthermore, more than half of the X-ray AGN in Antlia is hosted by its younger subcluster, centered on NGC 3258. We believe that this is because SMBH activity is enhanced in a dynamically young cluster compared to relatively relaxed clusters.
|
|
| 5. |
- Luo, Yuanze, et al.
(författare)
-
A Multiwavelength View of IC 860: What Is in Action inside Quenching Galaxies * * Herschel is an ESA space observatory with science instruments provided by European-led principal investigator consortia and with important participation from NASA.
- 2022
-
Ingår i: Astrophysical Journal. - : American Astronomical Society. - 1538-4357 .- 0004-637X. ; 938:1
-
Tidskriftsartikel (refereegranskat)abstract
- We present a multiwavelength study of IC 860, a nearby post-starburst galaxy at the early stage of transitioning from blue and star forming to red and quiescent. Optical images reveal a galaxy-wide, dusty outflow originating from a compact core. We find evidence for a multiphase outflow in the molecular and neutral gas phase from the CO position-velocity diagram and NaD absorption features. We constrain the neutral mass outflow rate to be ∼0.5 M ⊙ yr−1, and the total hydrogen mass outflow rate to be ∼12 M ⊙ yr−1. Neither outflow component seems able to escape the galaxy. We also find evidence for a recent merger in the optical images, CO spatial distribution, and kinematics, and evidence for a buried active galactic nucleus in the optical emission line ratios, mid-IR properties, and radio spectral shape. The depletion time of the molecular gas reservoir under the current star formation rate is ∼7 Gyr, indicating that the galaxy could stay at the intermediate stage between the blue and red sequence for a long time. Thus the timescales for a significant decline in star formation rate (quenching) and gas depletion are not necessarily the same. Our analysis supports the quenching picture where outflows help suppress star formation by disturbing rather than expelling the gas and shed light on possible ongoing activities in similar quenching galaxies.
|
|
| 6. |
|
|
| 7. |
- Ringborg, Ulrik, et al.
(författare)
-
The Porto European Cancer Research Summit 2021
- 2021
-
Ingår i: Molecular Oncology. - : Wiley. - 1574-7891 .- 1878-0261. ; 15:10, s. 2507-2543
-
Tidskriftsartikel (refereegranskat)abstract
- Key stakeholders from the cancer research continuum met in May 2021 at the European Cancer Research Summit in Porto to discuss priorities and specific action points required for the successful implementation of the European Cancer Mission and Europe's Beating Cancer Plan (EBCP). Speakers presented a unified view about the need to establish high-quality, networked infrastructures to decrease cancer incidence, increase the cure rate, improve patient's survival and quality of life, and deal with research and care inequalities across the European Union (EU). These infrastructures, featuring Comprehensive Cancer Centres (CCCs) as key components, will integrate care, prevention and research across the entire cancer continuum to support the development of personalized/precision cancer medicine in Europe. The three pillars of the recommended European infrastructures – namely translational research, clinical/prevention trials and outcomes research – were pondered at length. Speakers addressing the future needs of translational research focused on the prospects of multiomics assisted preclinical research, progress in Molecular and Digital Pathology, immunotherapy, liquid biopsy and science data. The clinical/prevention trial session presented the requirements for next-generation, multicentric trials entailing unified strategies for patient stratification, imaging, and biospecimen acquisition and storage. The third session highlighted the need for establishing outcomes research infrastructures to cover primary prevention, early detection, clinical effectiveness of innovations, health-related quality-of-life assessment, survivorship research and health economics. An important outcome of the Summit was the presentation of the Porto Declaration, which called for a collective and committed action throughout Europe to develop the cancer research infrastructures indispensable for fostering innovation and decreasing inequalities within and between member states. Moreover, the Summit guidelines will assist decision making in the context of a unique EU-wide cancer initiative that, if expertly implemented, will decrease the cancer death toll and improve the quality of life of those confronted with cancer, and this is carried out at an affordable cost.
|
|
